{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T13:42:59Z","timestamp":1769607779643,"version":"3.49.0"},"reference-count":30,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2008,6]]},"DOI":"10.1097\/rhu.0b013e3181772cca","type":"journal-article","created":{"date-parts":[[2009,3,5]],"date-time":"2009-03-05T14:12:37Z","timestamp":1236262357000},"page":"138-142","source":"Crossref","is-referenced-by-count":41,"title":["The Use of Procalcitonin Determinations in Evaluation of Systemic Lupus Erythematosus"],"prefix":"10.1097","volume":"14","author":[{"given":"Gerardo","family":"Quintana","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yimy F.","family":"Medina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cilia","family":"Rojas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andr\u00e9s","family":"Fernandez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9 F\u00e9lix","family":"Restrepo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Federico","family":"Rondon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio","family":"Iglesias","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-3-20210207","doi-asserted-by":"crossref","first-page":"2870","DOI":"10.1016\/S0021-9258(17)43228-5","article-title":"Identification of procalcitonin in a rat medullary thyroid carcinoma cell line.","volume":"259","author":"Birnbaum","year":"1984","journal-title":"J Biol Chem"},{"key":"R2-3-20210207","first-page":"520","article-title":"Principles and Practice of Endocrinology and Metabolism. 3rd ed.","author":"Becker","year":"2001"},{"key":"R3-3-20210207","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1097\/00024382-200116020-00004","article-title":"Procalcitonin and CGRP-1 mRNA expression in various human tissues.","volume":"16","author":"Russwurm","year":"2001","journal-title":"Shock"},{"key":"R4-3-20210207","first-page":"55","article-title":"Various human tissues express procalcitonin and CGRP-I mRNA.","volume":"2","author":"Russwurm","year":"2001","journal-title":"J Anaesth Intensivbehand"},{"key":"R5-3-20210207","first-page":"396","article-title":"Ubiquitous expression of the calcitonin-I gene in multiple tissues in response to sepsis.","volume":"86","author":"Muller","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"R6-3-20210207","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0022-2143(99)90053-7","article-title":"Procalcitonin expression in human peripheral blood mononuclear cells and its modulation by lipopolysaccharides and sepsis related cytokines in vitro.","volume":"134","author":"Oberhoffer","year":"1999","journal-title":"J Lab Clin Med"},{"key":"R7-3-20210207","first-page":"1","article-title":"Katacalcin and calcitonin immunoreactivity in different types of leukocytes indicates intracellular procalcitonin content.","volume":"1","author":"Oberhoffer","year":"1998","journal-title":"Cytokines"},{"key":"R8-3-20210207","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1097\/00003246-200002000-00028","article-title":"Procalcitonin behaves as a fast responding acute phase protein in vivo and in vitro.","volume":"28","author":"Nijsten","year":"2000","journal-title":"Crit Care Med"},{"key":"R9-3-20210207","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1056\/NEJM199902113400607","article-title":"Acute-phase proteins and other systemic responses to inflammation [erratum in N Engl J Med. 1999;340:1376].","volume":"340","author":"Gabay","year":"1999","journal-title":"N Engl J Med"},{"key":"R10-3-20210207","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1007\/s001340000624","article-title":"Procalcitonin as a marker of the systemic inflammatory response to infection.","volume":"26","author":"Reinhart","year":"2000","journal-title":"Intensive Care Med"},{"key":"R11-3-20210207","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0009-8981(02)00101-8","article-title":"Pathobiochemistry and clinical use of procalcitonin.","volume":"323","author":"Meisner","year":"2002","journal-title":"Clinica Chimica Acta"},{"key":"R12-3-20210207","first-page":"70","article-title":"Procalcitonina: una nueva herramienta diagn\u00f3stica en la infecci\u00f3n bacteriana.","volume":"119","author":"Name","year":"2002","journal-title":"Med Clin (Barc)"},{"key":"R13-3-20210207","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1097\/00006454-199910000-00008","article-title":"Comparison of procalcitonin with C-reactive protein, interleukin 6 and interferon-alpha for differentiation of bacterial vs. viral infections.","volume":"18","author":"Gendrel","year":"1999","journal-title":"Pediatr Infect Dis J"},{"key":"R14-3-20210207","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1002\/1529-0131(199707)40:7<1250::AID-ART9>3.0.CO;2-A","article-title":"Usefulness of procalcitonin for differentiation between activity of systemic autoimmune disease (systemic lupus erythematosus\/systemic antineutrophil cytoplasmic antibody-associated vasculitis) and invasive bacterial infection.","volume":"40","author":"Eberhard","year":"1997","journal-title":"Arthritis Rheum"},{"key":"R15-3-20210207","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1007\/BF02962246","article-title":"CRP levels in autoimmune disease can be specified by measurement of procalcitonin.","volume":"26","author":"Schwenger","year":"1998","journal-title":"Infection"},{"key":"R16-3-20210207","first-page":"15","article-title":"Is procalcitonin really a marker of sepsis?","volume":"8","author":"Meisner","year":"2001","journal-title":"Int J Intensive Care"},{"key":"R17-3-20210207","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1086\/514576","article-title":"Reliability of procalcitonin concentrations for the diagnosis of sepsis in critically ill neonates.","volume":"26","author":"Chiesa","year":"1998","journal-title":"Clin Infect Dis"},{"key":"R19-3-20210207","first-page":"1531","article-title":"Elevated procalcitonin levels in active Wegener's granulomatosis.","volume":"25","author":"Moosig","year":"1998","journal-title":"J Rheumatol"},{"key":"R20-3-20210207","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1136\/ard.62.4.337","article-title":"Can procalcitonin measurement help in differentiating between bacterial infection and other kinds of inflammatory processes?","volume":"62","author":"Del\u00e8vaux","year":"2003","journal-title":"Ann Rheum Dis"},{"key":"R21-3-20210207","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.jinf.2003.08.002","article-title":"Serum procalcitonin concentration in patients with Kawasaki disease.","volume":"48","author":"Okadaa","year":"2004","journal-title":"J Infection"},{"key":"R22-3-20210207","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1111\/j.1468-3083.2004.00907.x","article-title":"Serum interleukin-6, procalcitonin and C-reactive protein levels in subjects with active Beh\u00e7et's disease.","volume":"18","author":"Adam","year":"2004","journal-title":"J Eur Acad Dermatol Venerol"},{"key":"R23-3-20210207","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1002\/1529-0131(199803)41:3<566::AID-ART30>3.0.CO;2-U","article-title":"Limitations on the usefulness of procalcitonin as a marker of infection in patients with systemic autoimmune disease: comment on the article by Eberhard et al.","volume":"41","author":"Moosig","year":"1998","journal-title":"Arthritis Rheum"},{"key":"R24-3-20210207","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1002\/1529-0131(199803)41:3<567::AID-ART31>3.0.CO;2-Q","article-title":"Use of procalcitonin as a diagnostic test: comment on the article by Eberhard et al.","volume":"41","author":"Espinosa-Morales","year":"1998","journal-title":"Arthritis Rheum"},{"key":"R25-3-20210207","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1002\/1529-0131(199803)41:3<568::AID-ART32>3.0.CO;2-M","article-title":"Use of procalcitonin as a diagnostic test: comment on the article by Eberhard et al.","volume":"41","author":"Eberhard","year":"1998","journal-title":"Arthritis Rheum"},{"key":"R26-3-20210207","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1136\/ard.60.10.988","article-title":"Serum procalcitonin measurement for detection of intercurrent infection in febrile patients with SLE.","volume":"60, 1","author":"Shin","year":"2001","journal-title":"Ann Rheum Dis"},{"key":"R27-3-20210207","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/0140-6736(93)90277-N","article-title":"High serum procalcitonin concentrations in patients with sepsis and infection.","volume":"341","author":"Assicot","year":"1993","journal-title":"Lancet"},{"key":"R28-3-20210207","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1097\/01.CCM.0000050454.01978.3B","article-title":"2001 SCCM\/ESICM\/ACCP\/ATS\/SIS International Sepsis Definitions Conference.","volume":"31","author":"Levy","year":"2003","journal-title":"Crit Care Med"},{"key":"R29-3-20210207","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1097\/00003246-200004000-00057","article-title":"Procalcitonin: the marker of sepsis?","volume":"28","author":"Vincent","year":"2000","journal-title":"Crit Care Med"},{"key":"R30-3-20210207","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1097\/00003246-199704000-00009","article-title":"Cytokines, nitrite\/nitrate, soluble tumor necrosis factor receptor, and procalcitonin concentrations: comparisons in patients with septic shock, cardiogenic shock, and bacterial pneumonia.","volume":"25","author":"de Werra","year":"1997","journal-title":"Crit Care Med"},{"key":"R31-3-20210207","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1006\/cyto.1999.0607","article-title":"Procalcitonin and calcitonin gene-related peptide decrease LPS-induced TNF production by human circulating blood cells.","volume":"12","author":"Monneret","year":"1999","journal-title":"Cytokine"}],"container-title":["JCR: Journal of Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/journals.lww.com\/00124743-200806000-00003","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,10]],"date-time":"2021-04-10T07:01:21Z","timestamp":1618038081000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00124743-200806000-00003"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,6]]},"references-count":30,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2008]]}},"URL":"https:\/\/doi.org\/10.1097\/rhu.0b013e3181772cca","relation":{},"ISSN":["1076-1608"],"issn-type":[{"value":"1076-1608","type":"print"}],"subject":[],"published":{"date-parts":[[2008,6]]}}}